Tavneos Archives -

UK cost-effectiveness organisation NICE has recommended routine NHS use of a recently-approved therapy for two forms of ANCA-associated

CSL Vifor plans UK launch after NICE backs rare disease drug Tavneos

https://pharmaphorum.com/news/csl-vifor-plans-uk-launch-after-nice-backs-rare-disease-drug-tavneos/

Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in

Amgen splashes out on ChemoCentryx and its blockbuster hopeful

https://pharmaphorum.com/news/amgen-splashes-out-on-chemocentryx-and-its-blockbuster-hopeful/

ChemoCentryx has claimed FDA approval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active

Flash FDA approval sends ChemoCentryx spiralling upwards

https://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/

Tavneos